Reduced susceptibility towards pathogens, in particular oomycetes, such as downy mildew in lettuce and spinach

Details for Australian Patent Application No. 2005254660 (hide)

Owner Rijk Zwaan Zaadteelt en Zaadhandel B.V.

Inventors Dirks, Robert Helene Ghislain; Egelmeers, Petrus Lambertus Josephus; De Wit, Jacobus Petrus Cornelis; Schut, Johannes Wilhelmus; Van Dun, Cornelis Maria Petrus

Agent Cullen & Co

Pub. Number AU-B-2005254660

PCT Pub. Number WO2005/124108

Priority 04076729.5 16.06.04 EP

Filing date 10 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 3 September 2009

International Classifications

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

A01H 5/00 (2006.01) Products

A01H 5/02 (2006.01) Products - Flowers

A01H 5/12 (2006.01) Products - Leaves

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/124108 Priority application(s): WO2005/124108

21 June 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Reduced susceptibility towards pathogens, in particular oomycetes, such as downy mildew in lettuce and spinach

3 September 2009 Application Accepted

  Published as AU-B-2005254660

7 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254665-Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the same

2005254659-Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors